Description
Oncology nurse/patient navigators who participate in this BRIDGE Symposium will develop a working knowledge of cancer genetics/genomics. Navigators can then effectively educate patients and advocate for appropriate referrals to genetic professionals, ensuring suitable access to germline and tissue testing.
The role of Navigators as Genetic Extenders will be proposed, ultimately to enhance cancer care for patients and their families. The current state of the science and near future directions in cancer genetics/genomics will be addressed by a multidisciplinary faculty that includes genetics nurses, advanced practice nurses, certified genetic counselors, and researchers.
Learning Objectives:
- Describe basic concepts and principles in cancer genetics and genomics, specific to the navigator role.
- Recognize the shared decision- making process related to genetic/genomic testing, focusing on both pretest and posttest education and counseling.
- Identify at least 2 of the most common hereditary cancer syndromes, as well as proposed management guidelines.
- Describe at least 2 emerging technologies in tissue genetic testing (genomics) that are now or may soon affect cancer treatment or management.
- Distinguish basic clinical features that warrant referral for genetic/genomic testing, using case examples and pedigree reviews.
- Propose the role of Genetic Extender for Navigators particularly around gathering a relevant family history, fostering a multidisciplinary team, and evaluating educational resources.
Speaker(s):
- Jennifer
R. Klemp,
PhD, MPH, MA,
Associate Professor,
Kansas Medical Center, Department of Medicine
- Frank
dela Rama,
RN, MS, AOCNS, AGN-BC,
Clinical Nurse Specialist, Oncology / Genomics & Prostate Cancer Nurse Navigator,
Palo Alto Medical Foundation
- Kathy
A. Pratt,
BSN, RN, OCN, CBCN, ONN-CG,
Senior Clinical Program Coordinator/ Genetic Patient Navigator,
University of Texas Southwestern Medical Center, Harold Simmons Comprehensive Cancer Center
- Shelly
Cummings,
MS, CGC,
Director, Medical Affairs,
Myriad Oncology
- Ginger
Kreyling,
BSN, RN, CN-BN,
Genetic Counselor Extender/Oncology Nurse Navigator,
Ascension St. Vincent Evansville
- Stephanie
A. Cohen,
MS, LCGC,
Genetic Counselor,
Ascension St. Vincent
- Elisabeth
King,
RN, FNP, AOCNP, AGN,
Executive Director of Genomics and Precision Medicine,
City of Hope
- Leigha
Senter,
MS, CGC,
Associate Professor, Licensed Genetic Counselor,
The Ohio State University
- Kate
Reed,
MPH, ScM, CGC,
Director, Clinical Education Program,
The Jackson Laboratory
- Emily
Edelman,
MS, CGC,
Associate Director, Clinical Education Program,
The Jackson Laboratory
- Diane
Koeller,
MS, MPH, CGC,
Genetic Counselor,
Dana-Farber Cancer Institute
- Sara
Riordan,
MS, CGC,
"Director of Medical Education, Oncocyte President Elect, National Society of Genetic Counselors",
Oncocyte
